endocrinesystem-121228084635-phpapp01

Embed Size (px)

Citation preview

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    1/79

    Under the guidance of:Dr. Sandeep

    Tandon

    Professor and Head of Dept. of Pedodontics

    Dr. Ambika SinghRathore

    Dr. Rinku Mathur

    Dr .Shantanu Jain

    Dr. Tripti Sharma Ra

    1

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    2/79

    CONTENT:

    Introduction

    Evolution of Endocrine system

    Chemical characteristics of Hormones

    Regulation of Hormone Release

    Hypothalamus & its Hormone

    Various glands and their importance

    Disorders of Endocrine system common inChildren

    References2

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    3/79

    INTRODUCTION:

    Constant internal environment

    (i.e., homeostasis) should be maintained.

    Two systems help ensure communication:

    Rapid transmission Long-lasting regulatoryaction

    Both systems interact: Stimuli from the nervoussystem can influence the release of certain hormonesand vice versa.

    NERVOUSSYSTEM

    HORMONAL

    Neuroendocrine

    3

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    4/79

    EVOLUTIONOFENDOCRINESYSTEM The nervous systemcoordinates rapid and precise responses to

    stimuli using action potentials.

    The endocrine system maintains homeostasis and long-termcontrol using chemical signals.

    The most primitive endocrine systems seem to be those of theneurosecretorytype, in which the nervous system either secretesneurohormones directly into the circulation or stores them inneurohemal organs (neurons whose endings directly contactblood vessels, allowing neurohormones to be secreted into the

    circulation), from which they are released in large amounts asneeded.

    True endocrine glands probably evolved later in the evolutionaryhistory of the animal kingdom as separate, hormone-secretingstructures.

    4

    http://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossN.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossA.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossH.htmlhttp://www.britannica.com/EBchecked/topic/410737/neurosecretory-cellhttp://www.britannica.com/EBchecked/topic/410635/neurohormonehttp://www.britannica.com/EBchecked/topic/410631/neurohemal-organhttp://www.britannica.com/EBchecked/topic/69887/blood-vesselhttp://www.britannica.com/EBchecked/topic/69887/blood-vesselhttp://www.britannica.com/EBchecked/topic/69887/blood-vesselhttp://www.britannica.com/EBchecked/topic/69887/blood-vesselhttp://www.britannica.com/EBchecked/topic/410631/neurohemal-organhttp://www.britannica.com/EBchecked/topic/410631/neurohemal-organhttp://www.britannica.com/EBchecked/topic/410631/neurohemal-organhttp://www.britannica.com/EBchecked/topic/410635/neurohormonehttp://www.britannica.com/EBchecked/topic/410737/neurosecretory-cellhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossH.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossA.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossA.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossA.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossN.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossN.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossN.html
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    5/79

    CONVERGENT EVOLUTION:

    Similarities among the endocrine systems ofcrustaceans, arthropods, and vertebrates.

    The vertebrate endocrine system consists

    of glands (pituitary, thyroid, adrenal), and

    diffuse cell groups scattered in epithelial tissues.

    Endocrine glands arise during development for all threeembryologic tissue layers (endoderm, mesoderm,ectoderm).

    The type of endocrine product is determined by whichtissue layer a gland originated in.

    Glands of ectodermal and endodermal origin: peptideand amine hormones;

    Mesodermal origin glands:hormones based on lipids. 5

    http://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossM.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossM.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossM.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.htmlhttp://www.emc.maricopa.edu/faculty/farabee/biobk/BioBookglossE.html
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    6/79

    WHAT ARE HORMONES?????

    ( TOSPURON)

    Hormones are molecules thatare produced by endocrine

    glands:i. The hypothalamus,

    ii. Pituitary gland,

    iii. Adrenal glands,

    iv. Gonads, (i.e., testes andovaries),

    v. Thyroid gland,

    vi. Parathyroid glands, and

    vii. Pancreas6

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    7/79

    The term endocrine implies that in response to

    specific stimuli, the products of those glands are

    released into the bloodstream.

    The hormones then are carried via the

    blood to their target cells.

    The target cells for each hormone are characterized by

    the presence of docking molecules(i.e., receptors) for

    the hormone that are located either on the cell surface

    or inside the cell. The interaction between the hormone and its receptor

    triggers a cascade of biochemical reactions in the target

    cell that eventually modify the cells function or activity.7

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    8/79

    CHEMICALCHARACTERISTICSOFHORMONES

    Amines (from tyrosine)I. hydroxylation - catecholaminesII. iodination - thyroid hormones

    Peptides/proteins Steroids (from cholesterol)

    I. adrenocorticoidsII. sex hormones

    III. active metabolites of vitamin D

    Their mechanisms of action (e.g., whether they canenter their target cells and how they modulate theactivity of those cells) also differ.

    8

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    9/79

    MECHANISMOFACTION:

    STEROIDS: produced by gonads; structure similar to

    cholesterol.

    Enter their target cells and interact with the

    cytoplasm or in the cell nucleus

    Hormone-receptor complexes bind to certain regions

    of the cells genetic material (i.e., the DNA)

    Regulating the activity of specific hormone-responsive genes

    9

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    10/79

    MECHANISMOFACTION:

    10

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    11/79

    Amino acid derivatives:

    are modified versions of building blocks of proteins.

    thyroid gland & adrenal glands (i.e., the adrenal medulla)

    Enter the cell, where they interact with receptor proteins that

    are already associated with specific DNA regions. The

    interaction modifies the activity of the affected genes.

    Polypeptide and protein hormones:

    found primarily in the hypothalamus, pituitary gland, and

    pancreas

    Because of their chemical structure, the polypeptide and

    protein hormones cannot enter cells. Instead, they interactwith receptors on the cell surface.

    11

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    12/79

    REGULATIONOFHORMONERELEASE

    Constant feedback from the target glands to the

    hypothalamus and pituitary gland ensures that the

    activity of the hormone system involved remains

    within appropriate boundaries.

    To maintain the bodys homeostasis

    Negative feedback mechanism

    Short-loop feedback Positive-feedback mechanisms

    12

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    13/79

    Negative Feedback Loop

    13

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    14/79

    Positive Feedback Loop

    14

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    15/79

    THEHYPOTHALAMUSANDITSHORMONES

    Why is the Hypothalamus so Important?Eating and drinking,

    Sexual functions and behaviors,

    Blood pressure and heart rate,Body temperature maintenance,

    The sleep-wake cycle, and

    Emotional states (e.g., fear, pain, anger, andpleasure)

    15

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    16/79

    Neurosecretory cells

    16

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    17/79

    THEHYPOTHALAMIC-HYPOPHYSEAL

    PORTALSYSTEM

    17

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    18/79

    hypothalamic nuclei

    superiorhypophysealartery superficial

    capillary plexus

    trabecular artery deepcapillary plexus

    inferiorhypophysealartery

    long portal veins

    superficialcapillary plexus

    18

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    19/79

    hypothalamic nuclei

    superiorhypophysealartery superficial

    capillary plexus

    trabecular artery deepcapillary plexuslong portal veins

    short portal veins

    inferiorhypophysealartery

    19

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    20/79

    hypothalamic nuclei

    superiorhypophysealartery superficial

    capillary plexus

    trabecular artery deepcapillary plexuslong portal veins

    short portal veinssecondary

    capillaryplexus

    adeno-

    hypophysealcapillaryplexus inferior

    hypophysealartery

    20

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    21/79

    superiorhypophysealartery superficial

    capillary plexus

    deepcapillary plexuslong portal veins

    short portal veins

    hypothalamic nuclei

    trabecular artery

    adeno-

    hypophysealcapillaryplexus

    hypophyseal vein

    inferiorhypophysealartery

    21

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    22/79

    Corticotrophin (CRH) Somatostanin

    ACTH

    Gonadotropin (GnRH) Dopamine

    LH & FSH

    Thyrotropin (TRH) TSH

    Growth-Hormone (GHRH)

    GH

    HYPOTHALAMIC

    HORMONES

    RELEASING INHIBITING

    22

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    23/79

    23

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    24/79

    THEPITUITARYANDITSMAJORHORMONES

    24

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    25/79

    There is also an intermediate lobeinmany animals,but is rudimentary in humans.

    For instance, in fish, it is believed to controlphysiological color change.

    In adult humans, it is just a thin layer of cells

    between the anterior and posterior pituitary.The intermediate lobe produces melanocyte-stimulating hormone(MSH), although thisfunction is often (imprecisely) attributed to theanterior pituitary.

    INTERMEDIATE LOBE

    25

    http://en.wikipedia.org/wiki/Pars_intermediahttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Melanocyte-stimulating_hormonehttp://en.wikipedia.org/wiki/Pars_intermedia
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    26/79

    GROWTH HORMONE Most abundant of the pituitary hormones

    Pivotal role in controlling the bodys growth

    and development.

    1. Stimulates the linear growth of the bones;

    2. Promotes the growth of internal organs, fat (i.e.,adipose) tissue, connective tissue, endocrine glands,and muscle; and

    3. Controls the development of the reproductive organs.

    4. GH affects carbohydrate, protein, and fat (i.e., lipid)metabolism.

    GH levels in the blood are highest during earlychildhood and puberty and decline thereafter. 26

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    27/79

    27

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    28/79

    INDIRECTACTIONOFGROWTHHORMONE

    28

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    29/79

    Two hypothalamic hormones control GH release:

    (1) GHRH:stimulates GH release,

    (2) Somatostatin:inhibits GH release.

    Shor t -loop feedback com ponent :

    GH acts on the hypothalamus to stimulate somatostatin

    release.

    In addition, GH release is enhanced by

    Stress, such as low blood sugar levels (i.e.,

    hypoglycemia) or severe exercise, and by the onset of

    deep sleep.

    Acute and chronic alcohol consumption have been

    shown to reducethe levels of GH and IGF-1 in the

    blood. 29

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    30/79

    PROLACTIN. Central role in the development of the female

    breast and in the initiation and maintenance oflactation after childbirth.

    Factors control Prolactin release:

    1. Response to the rise in estrogen levels in theblood that occurs during pregnancy.

    2. In nursing women, Prolactin is released inresponse to suckling by the infant.

    3. Dopamine, which has an inhibitory effect.

    4. Alcohol consumption by nursing women caninfluence lactation both through its effects on therelease of prolactin and oxytocin. 30

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    31/79

    POSTERIOR PITUITARY:

    31

    VASOPRESSIN

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    32/79

    VASOPRESSIN Vasopressin (arginine vasopressin, AVP; anti-

    diuretic hormone, ADH)is a peptide hormone

    formed in the hypothalamus, then transported viaaxons to, and released from, the posterior pituitary.

    Two principles site of action:

    KIDNEY & BLOOD VESSEL

    32

    http://www.cvphysiology.com/Blood%20Pressure/BP008.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP008.htm
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    33/79

    MECHANISMSREGULATINGTHERELEASEOFAVP

    Hypovolemia:decreased central venouspressure, the decreased firing of atrial stretchreceptors leads to an increase in AVP release.

    Hypotension,whichdecreases arterial

    baroreceptor firingand leads to enhancedsympathetic activity, increases AVP release.

    Angiotensin II receptors located in a region ofthe hypothalamus regulate AVP release anincrease in angiotensin II simulates AVP release.

    Increased sympathetic activation stimulatesAVP release

    33

    http://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htmhttp://www.cvphysiology.com/Blood%20Pressure/BP012.htm
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    34/79

    OXYTOCIN HORMONE

    I. Stimulates the contractions of the

    uterus during childbirth.

    I. In nursing women, the hormone activates milkejection in response to suckling by the infant

    (i.e., the so-called let-down reflex).

    34

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    35/79

    THEADRENALGLANDSANDTHEIRHORMONES

    35

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    36/79

    Action of Cortisol:

    1. Cortisol increases glucose levels in the blood bystimulating gluconeogenesis in the liver andpromotes the formation of glycogen in the liver.

    2. Reduces glucose uptake into muscle and adipose

    tissue,3. Promotes protein and lipid breakdown into products

    (i.e., amino acids and glycerol, respectively) that canbe used for gluconeogenesis.

    4. Protect the body against the deleterious effects ofvarious stress factors.

    5. Suppress tissue inflammation in response to injuriesand to reduce the immune response to foreignmolecules. 36

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    37/79

    ACTION OF ALDOSTERONE:

    Regulate the bodys water and electrolyte balance.

    Conserve sodium and to excrete potassium from thebody.

    Reducing water excretion and increasing blood

    volume.

    Decreases the ratio of sodium to potassiumconcentrations in sweat and saliva, therebypreventing sodium loss via those routes.

    Controlled primarily by another hormone system, thereninangiotensin system, which also controls kidneyfunction. 37

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    38/79

    THETHYROIDANDITSHORMONES

    38

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    39/79

    THYROID HORMONE PRODUCTION

    39

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    40/79

    THYROID HORMONE PRODUCTION

    40

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    41/79

    ACTIONOFTHYROIDHORMONE

    Stimulates the production of certain proteins

    involved in heat generation in the body, afunction that is essential for maintaining bodytemperature in cold climates.

    Promotes other metabolic processes involvingcarbohydrates, proteins, and lipids that helpgenerate the energy required for the bodysfunctions.

    Plays an essential role in the development of thecentral nervous system during late fetal and

    early postnatal developmental stages. Required for the normal development of teeth,

    skin, and hair follicles as well as for thefunctioning of the nervous, cardiovascular, andgastrointestinal systems

    41

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    42/79

    Parafollicular C cells) in the thyroid gland produce

    calcitonin,a hormone that helps maintain normal

    calcium levels in the blood.

    Specifically, calcitoninlowers calcium levels in the

    blood by reducing the release of calcium from the

    bones; inhibiting the constant erosion of bones

    (i.e., bone resorption), which also releasescalcium; and inhibiting the reabsorption of calcium

    in the kidneys.

    42

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    43/79

    THEPARATHYROIDGLANDS

    ANDTHEIRHORMONES

    43

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    44/79

    ROLEOFPARATHYROIDHORMONE

    Increases calcium levels in the blood, helping to

    maintain bone quality and an adequate supply ofcalcium.

    Causes re-absorption of calcium from and excretion

    of phosphate in the urine.

    Promotes the release of stored calcium from thebones as well as bone resorption.

    PTH stimulates the absorption of calcium from the

    food in the gastrointestinal tract.

    Functions facilitated by a substance called1,25-dihydroxycholecalciferol, a derivative ofvitamin D. 44

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    45/79

    CALCIUMHOMEOSTASIS

    45

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    46/79

    THEPANCREASANDITSHORMONES

    46

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    47/79

    TWODISTINCTLYDIFFERENTFUNCTIONS

    EXOCRINE ENDOCRINE

    Digestive Enzymes

    Islets of

    Langerhans

    PANCREAS

    INSULIN GLUCAGON

    47

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    48/79

    INSULIN & GLUCAGON

    Beta cells of Islet Alpha cells of Islet

    Blood sugar-lowering Increases blood glucose levels

    hormone Actions opposite to insulin

    Effect of Insulin:

    1. Inhibits gluco-neogenesis

    2. Insulin promotes the formation of storage formsof energy (e.g., glycogen, proteins, and lipids)and suppresses the breakdown of those storednutrients. 48

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    49/79

    REGULATION OF BLOOD GLUCOSE

    LEVELS

    49

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    50/79

    THEGONADSANDTHEIRHORMONES

    OVARIES AND TESTES

    They produce the germ cells.Synthesize steroid sex hormones that are

    necessary for the development and function ofboth female and male reproductive organs and

    secondary sex characteristics.Affect the metabolism of carbohydrates and

    lipids, the cardiovascular system, and bonegrowth and development.

    50

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    51/79

    51

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    52/79

    DIABETES

    ''Type 1 diabetes is growing by 5% per year amongpre-school children in India.

    It is estimated that 70,000 children, who are under15 years, developjuvenile type 1 diabeteseach year(almost 200 children a day!).

    Symptoms of Diabetes in Children:

    Stomach pains,

    Headaches

    Behaviour problems Weight loss, thirst, tiredness and frequent urination.

    Detected through the presence of ketoacidosis52

    http://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.htmlhttp://www.fatfreekitchen.com/diabetes/diabetes.html
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    53/79

    CAUSES:

    Type I (Juvenile Diabetes): bodys inabilityto produce insulin

    Genetic factors; environmental factors

    Increased Type 2 Diabetes: linkedoverwhelmingly to lifestyle changes that havecontributed to increased weight problems andlack of activity in children. 53

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    54/79

    TREATMENT:

    INSULIN: The advent of insulin pumps for

    administration has allowed many children addedflexibility in their daily lives.

    Monitoring blood sugar levels

    Crucial factor

    Diet:reduced consumption of fats and sugars,

    intake fibers, vegetables and fruits.

    Exercise: helps in lowering blood glucose levels

    of the body54

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    55/79

    COMPLICATIONS

    Sudden hypoglycemia & hyperglycemia

    Immediately giving the child a glucose tablet orglucose beverage

    LONG-TERM COMPLICATIONS

    Problems of the kidney, heart, lungs, eyes, feetand nerves.

    High blood sugar or high cholesterol levels55

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    56/79

    GIGANTISM Gigantism refers to abnormally

    high linear growth due toexcessive action of insulin-like

    growth factor-I (IGF-I) while the

    epiphyseal growth plates are

    open during childhood.

    Acromegaly is the same disorderof IGF-I excess when it occurs

    after the growth plate cartilage

    fuses in adulthood.

    Robert Wadlow, called the Alton

    giant,who stood 8 feet 11 inches

    tall at the time of his death in his

    mid-20s 56

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    57/79

    CAUSES

    Causes of excess IGF-I action may bedivided into 3 categories:

    Those originating from primary GH excessreleased from the pituitary;

    Those caused by increased GH-releasinghormone (GHRH) secretion or hypothalamicdysregulation; and

    Hypothetically, those related to the excessiveproduction of IGF-binding protein, whichprolongs the half-life of circulating IGF-I. 57

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    58/79

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    59/79

    PITUITARYDWARFISM The achondroplastic

    dwarf has anorthopedic reason forhaving short limbs anda short spinal

    colum. The pituitarydwarflacks growthhormone (an endocrinereason).

    SYMPTOMS: GH Deficiency

    Low blood sugar59

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    60/79

    RISKFACTORS:

    Disease of the hypothalamus of the brain

    Disease of the front of the pituitary gland in the brain

    Newborns who had some type of serious medical event (such

    as a lack of oxygen) happen in the perinatal period, are at risk

    for the type of growth hormone deficiency caused by damageto the hypothalamus.

    TREATMENT:

    Treatment with human growth hormone

    theoretically corrects the deficiency, but ismost successful when the child is young. It mustbe given by injection.

    60

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    61/79

    PRECOCIOUSPUBERTY Precocious puberty

    describes pubertyoccurring at an unusuallyearly age.

    CAUSES:

    Central:

    damage to the inhibitorysystem of the brain

    hypothalamic hamartomaproduces pulsatile

    gonadotropin-releasinghormone(GnRH)

    Langerhans cellhistiocytosis 61

    http://en.wikipedia.org/wiki/Pubertyhttp://en.wikipedia.org/wiki/Hypothalamic_hamartomahttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Langerhans_cell_histiocytosishttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Gonadotropin-releasing_hormonehttp://en.wikipedia.org/wiki/Hypothalamic_hamartomahttp://en.wikipedia.org/wiki/Hypothalamic_hamartomahttp://en.wikipedia.org/wiki/Puberty
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    62/79

    PERIPHERALCAUSES

    Secondary sexual development induced by sex

    steroidsfrom other abnormal sources isreferred to asperipheral precocious puberty.

    Causes can include: Endogenous sources

    gonadaltumors (such as arrhenoblastoma)

    adrenaltumors

    germ cell tumor

    congenital adrenal hyperplasia

    McCuneAlbright syndrome Exogenous hormones

    Environmental

    As treatment for another condition62

    http://en.wikipedia.org/wiki/Sex_steroidhttp://en.wikipedia.org/wiki/Sex_steroidhttp://en.wikipedia.org/wiki/Gonadhttp://en.wikipedia.org/wiki/Arrhenoblastomahttp://en.wikipedia.org/wiki/Adrenalhttp://en.wikipedia.org/wiki/Germ_cell_tumorhttp://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasiahttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/McCune%E2%80%93Albright_syndromehttp://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasiahttp://en.wikipedia.org/wiki/Germ_cell_tumorhttp://en.wikipedia.org/wiki/Adrenalhttp://en.wikipedia.org/wiki/Arrhenoblastomahttp://en.wikipedia.org/wiki/Gonadhttp://en.wikipedia.org/wiki/Sex_steroidhttp://en.wikipedia.org/wiki/Sex_steroid
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    63/79

    TREATMENT

    GnRH agonists stimulate the pituitary to releaseFollicle Stimulating Hormone(FSH) andLuteinizing Hormone(LH).

    One possible treatment is with anastrozole.Histrelinacetate.

    63

    PEDIATRIC CUSHINGS SYNDROME

    http://en.wikipedia.org/wiki/Follicle_Stimulating_Hormonehttp://en.wikipedia.org/wiki/Luteinizing_Hormonehttp://en.wikipedia.org/wiki/Anastrozolehttp://en.wikipedia.org/wiki/Histrelinhttp://en.wikipedia.org/wiki/Histrelinhttp://en.wikipedia.org/wiki/Anastrozolehttp://en.wikipedia.org/wiki/Luteinizing_Hormonehttp://en.wikipedia.org/wiki/Follicle_Stimulating_Hormone
  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    64/79

    PEDIATRIC CUSHINGS SYNDROME

    (CS)

    Rare in childhood and adolescence. Caused by prolonged exposure to excessive

    glucocorticoids which can be secreted endogenouslyor administered exogenously.

    Supra-physiological doses of exogenous gluco-corticoids in the form of topical, inhaled or oralcorticosteroids.

    Eczema and asthma are common conditions in

    childhood often requiring treatment withcorticosteroids.

    64

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    65/79

    65

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    66/79

    66

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    67/79

    TREATMENT

    Primary adrenal lesions

    Surgical excision is the first-line therapy for acortical-secreting ACT.

    Mitotane therapy appears to be the treatmentof choice

    Cushings disease

    Medical therapies such as MetyraponeandKetoconazoleto lower serum cortisol levels canbe used as a short-term measure, but cannot berecommended as long-term therapy. 67

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    68/79

    THYROID DISORDERS

    Thyroid disease occurs lessfrequently in children than in adults, the signsand symptoms can be similar.

    Congenital hypothyroidism

    Affects infants at birth, and occurs in about 1 in4000 live-born babies.

    Loss of thyroid function, due to the thyroidgland failing to develop normally.

    Enzyme defect leading to deficient hormoneproduction, iodine deficiency and a brainpituitary gland abnormality.

    68

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    69/79

    Within the first week of life, a heelprick blood sampleistaken to assess an infant's thyroid hormone level.

    Infant is immediately given thyroid hormone replacement

    therapy (T4 thyroxine). Normal growth and developmentshould then continue, with no adverse effects on the child'smental capacity.

    Subtle symptoms: Severe:

    1. Poor feeding Poor growth and development2. Constipation Dry skin & hair3. Low body temperature Slow tendon reflex4. Slow pulse Enlarged tongue5.

    Prolonged jaundice, Umbilical hernia6. Increased sleepiness Puffiness & swelling7. Decreased crying.

    69

    H

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    70/79

    HYPERTHYROIDISMINNEWBORNS

    Overactive thyroid gland: referred to as

    NEONATAL HYPERTHYROIDISM.

    If the mother has Graves' disease, the thyroid-

    stimulating antibodies in her blood can cross theplacenta and stimulate the unborn child's thyroidgland,thus producing too much thyroid hormone.

    Some newborns may hardly be affected if the levels

    of antibodies are low. No treatment may be necessary as the mother's

    antibodies will soon clear from the baby'sbloodstream, usually within 2 to 3 months.

    70

    NEWBORNS WITH ADVANCED HYPERTHYROIDISM

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    71/79

    NEWBORNSWITHADVANCEDHYPERTHYROIDISM

    TREATMENT

    Anti-thyroid drugs is safe and effective, and will only beneeded for a short period of time, until the stimulating

    antibodies pass from the baby's bloodstream.If the mother is on a high dose of anti-thyroid medication,

    the diagnosis can be delayed by about a week until theinfant clears the anti-thyroid medication.

    EXTREMELY FASTPULSE

    IRRITABILITY

    FLUSHED MOIST SKIN

    INFANT TENDS TO BE THIN &LONG

    71

    H '

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    72/79

    HASHIMOTO'STHYROIDITIS

    The most common cause of

    hypothyroidismin childrenand adolescents isHashimoto's thyroiditis, anautoimmune disease.

    As the thyroid gland becomesincreasingly underactive,physical and mental changeswill become more obvious.

    Symptoms of hypothyroidismdevelop very slowly

    72

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    73/79

    SIGNSANDSYMPTOMS

    The first sign is that the child's growth ratedecreases unexpectedly and skeletaldevelopment is delayed.

    GOITRE

    DecreasedEnergy

    Lethargy

    Dry Itchy Skin&

    Constipation

    WEIGHTGAIN

    PoorConcentration 73

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    74/79

    TREATMENT

    Thyroid hormone replacement istaken daily for life.

    The dosage of thyroid hormone needs to be age-appropriate, as the body's demands for thyroid

    hormone vary with age.

    SIDE-EFFECTS:In children who have had long-standing

    hypothyroidism, ultimate height potential may bepartly lost.As the child regains normal thyroid function,

    behavioural problems may arise as their physicaland mental processes speed up

    74

    GRAVES' DISEASE

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    75/79

    GRAVES DISEASE

    The most common causeof hyperthyroidism inchildren and adolescentsis an autoimmunecondition called Graves'disease.

    In Graves' disease thebody produces antibodiesthat stimulate the thyroidgland uncontrollably, tomake too much thyroidhormone.

    75

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    76/79

    SIGNS AND SYMPTOMS

    Increased Energy,

    hyperactive, restless, Easilydistracted

    Enlarged Thyroid Gland, fastpulse, nervousness, heat

    intolerance, weight loss

    Accelerated growth rate,Shaky hands

    Muscle weakness, diarrhoea,and Sleep & behavioural

    disturbances.76

    TREATMENT

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    77/79

    TREATMENT Propylthiouracil (PTU) or Carbimazole.

    Period of 'block and replace therapy' (anti-thyroiddrugs as well as thyroxine) is useful.

    Throughout a child's treatment, thyroid hormone levels willneed to be monitored regularly, along with their clinicalsymptoms.

    SIDE EFFECTSAnti-thyroid drugs can, however, occasionally stop the

    production of white blood cells or platelets.

    Sore throats, mouth ulcers, excessive bruising or skinrashes can indicate this.

    The only safe action is to stop the medication until afterthe result of the blood test.

    77

    REFERENCES

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    78/79

    REFERENCES: Susanne Hiller-Sturmhfel and Andrzej Bartke. The Endocrine

    Syste An Overview.Alcohol Health & Research World; Vol.22(3):1998; 153-64

    Ashley B. Grossman, Martin O. Savage.Pediatric CushingsSyndrome: Clinical Features, Diagnosis, and Treatment.ArqBras Endocrinol Metab 2007;51/8:1261-1271)

    Kim E. Barrett, Susan M. Barman. GanongsReview of MedicalPhysiology;Vol.23:451-568

    Arthur C. Guyton. Textbook of Medical Physiology 10thedi;993-

    1019

    K. Sembulingham. Essentials Of Medical Physiology;3rdedi;667-714 78

  • 8/13/2019 endocrinesystem-121228084635-phpapp01

    79/79

    Presented by:

    Dr. Ruby Kharkwal1styear postgraduate studentDepartment of Pedodontics

    79